What sizes are available for Flavin containing monooxygenase 4/FMO4 Rabbit Polyclonal Antibody?

Flavin containing monooxygenase 4/FMO4 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Flavin containing monooxygenase 4/FMO4 Rabbit Polyclonal Antibody

Q: What is the catalog number for Flavin containing monooxygenase 4/FMO4 Rabbit Polyclonal Antibody?

The catalog number for Flavin containing monooxygenase 4/FMO4 Rabbit Polyclonal Antibody is orb97010.

Product Specifications

Product Name Alternative

Dimethylaniline monooxygenase [N-oxide-forming] 4; 1.14.13.8; Dimethylaniline oxidase 4; Hepatic flavin-containing monooxygenase 4; FMO 4; FMO4; FMO2

UniProt

P31512

Reactivity

Human, Mouse, Rat

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

A synthetic peptide corresponding to a sequence at the N-terminus of human Flavin containing monooxygenase 4, different from the related rat sequence by two amino acids, and from the related mouse sequence by three amino acids.

Target

Dimethylaniline monooxygenase [N-oxide-forming] 4

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Metabolism Research, Pharmacology & Drug Discovery, Signal Transduction

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Immunohistochemistry (Paraffin-embedded Section), 0.5-1μg/ml, Rat, Human Western blot, 0.1-0.5μg/ml, Human, Mouse, Rat

Form

Lyophilized

Molecular Weight

95 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

IHC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.